News and Article
Weight loss drug Ozempic linked to lower depression and anxiety risk People with diabetes have a higher risk of depression and anxiety. GLP-1 receptor agonists
May 10, 2026
No Comments
Weight loss drug Ozempic linked to lower depression and anxiety risk People with diabetes have a higher risk of depression and anxiety. GLP-1 receptor agonists
Esketamine (Spravato) Overview Esketamine, sold as Spravato, is a prescription nasal spray for certain forms of severe depression. It is a ketamine-derived medication that works
Sign up our newsletter to get update information, news and free insight.
